ClinicalTrials.Veeva

Menu

Vascular Inflammation Stratified by Body Size Phenotype

K

Korea University

Status

Completed

Conditions

Obesity
Atherosclerosis
Metabolic Syndrome

Study type

Observational

Funder types

Other

Identifiers

NCT01979068
PET_MONW

Details and patient eligibility

About

  • Vascular Inflammation is a key factor in both the pathogenesis and outcome of atherosclerosis. 18FDG-PET is a promising novel tool for identifying and quantifying vascular inflammation within atherosclerotic plaque
  • Recently, unique subsets of obese individuals, such as metabolically obese but normal weight (MONW) and metabolically healthy obese (MHO), have been getting an attention
  • Therefore, the purpose of this study is to examine the relationship of vascular inflammation,measured by FDG-PET, with various body sized phenotypes

Enrollment

250 patients

Sex

All

Ages

20 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Healthy patients for visiting routine medical check in our clinic

Exclusion criteria

  • history of CVD (myocardial infarction, unstable angina, stroke, or cardiovascular revascularization)
  • stage 2 hypertension (resting blood pressure, ≥160/100 mmHg)
  • history of inflammatory conditions that affect the study results
  • taking medications that might affect inflammatory status, including steroid and non-steroidal anti-inflammatory drug within 6 months
  • or malignancy or severe renal or hepatic disease

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems